Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Acuren Corporation Announces Commencement of Trading on the OTCQX Market

TOMBALL, Texas–(BUSINESS WIRE)–Acuren Corporation (the “Company” or “Acuren”) (OTCQX: TICA) announces that, effective as of today, its common stock has qualified to trade on the OTCQX Market under the symbol “TICA”. Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.

“We are pleased to begin trading on the OTCQX Market, which marks an important step in increasing access to our shares to a wider range of investors,” said Talman Pizzey, CEO of Acuren Corporation. “This milestone advances our strategy to build a world-leading testing, inspection, certification and compliance organization while enabling shareholders to participate in our long-term value creation. With our strong year-to-date results and robust balance sheet, we look forward to continue building on our success with broadened reach and awareness of the Acuren growth story.”

Additional Information for Existing Holders of Acuren Common Stock

The new CUSIP number for the Company’s common stock is 00510N102. The Company’s common stock (which converted from ordinary shares upon the Company’s domestication on December 16, 2024) is now eligible for movement into participant accounts at the Depository Trust & Clearing Corporation (“DTC”) (“DTC Eligibility”). The Company’s fomer ordinary share ISIN of VGG0093S1092 has been disabled and the new common stock ISIN US00510N1028 is now active. Holders of the Company’s common stock currently held as depositary interests through the CREST system operated by Euroclear UK & International Limited (“CREST”) may now transfer such common stock from a CREST participant account in the UK, to a DTC participant account in the US by contacting their broker or other custodian to confirm the DTC Eligibility and requesting a movement of their position from a CREST participant account into a DTC participant account.

CREST participants may contact the Global Transactions team at Computershare, the Company’s agent, by e-mail at uk.globaltransactions@computershare.com with any questions regarding transfers of depositary interests out of CREST and into DTC.

Registered holders of the Company’s common stock should receive a Direct Registration System (DRS) statement advice evidencing the new CUSIP and DTC status and may request that their broker transfer the shares via the DRS profile process. Computershare may be contacted at web.queries@computershare.com or 1-866-644-4127 US, Canada, Puerto Rico/1-781-575-2906 non-US.

Warrants issued by the Company are expected to be subject to a change in ISIN from VGG0093S1175 to US00510N1101, but at this time, the Company’s warrants are not eligible for entry into DTC.


About Acuren:

Acuren is a leading provider of critical asset integrity services. The company operates primarily in North America serving a broad range of industrial markets. It provides these essential and often compliance-mandated (often at customer locations) services in the industrial space and is focused on the recuring maintenance needs of its customers. The work Acuren does fits in the service category referred to as Testing, Inspection and Certification (TIC) including Nondestructive Testing (NDT) in the field and the laboratory and in-lab destructive testing capabilities. More information can be found at https://www.acuren.com/.

Forward-Looking Statements and Disclaimers:

This press release does not constitute or form part of any offer or invitation to purchase, otherwise acquire, issue, subscribe for, sell or otherwise dispose of any securities, nor any solicitation of any offer to purchase, otherwise acquire, issue, subscribe for, sell, or otherwise dispose of any securities of the Company.

This press release contains forward-looking statements which are based on the Company’s expectations, intentions and projections regarding the eligibility of the Company’s warrants to move to DTC. Prospective investors are cautioned not to place undue reliance on forward-looking statements, given certain risks and uncertainties, including that the warrants may not become DTC eligible. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts

Investor Relations Inquiries:

Dan Scott / Rodny Nacier

ICR Inc.

IR@acuren.com

Seth Weber

VP Investor Relations

Seth.weber@acuren.com

#FOLLOW US ON INSTAGRAM